Клиническое значение поражения ЛОР-органов у детей, больных муковисцидозом, и их лечение на современном этапе


Капранов Н.И., Мартынова И.В., Мосина В.В., Каширская Н.Ю.

Медико-генетический научный центр РАМН, Москва. Детская городская клиническая больница № 13 им. Н.Ф. Филатова, Москва. Российский научно-практический центр аудиологии и слухопротезирования ФМБА, Москва.
Указывается на связь муковисцидоза (МВ) с хроническим риносуинуситом (ХРС) и полипозом носа. Подчеркивается, что наличие ХРС значительно утяжеляет течение МВ, приводит к снижению показателей легочной функции, возрастанию колонизации синегнойной палочкой и ее хронической инфекции. Рассмотрены патогенез полипозного ХРС, его клиническая симптоматика и диагностика. Подробно обсуждаются консервативные и хирургические методы лечения этого заболевания, в т. ч. при развитии ХРС на фоне МВ.

Литература


1. Муковисцидоз. Современные достижения и актуальные проблемы. Методические рекомендации. Издание второе (первое 2001) переработанное и дополненное / Под ред. Капранова Н.И., Каширской Н.Ю. М., 2005. 109 с.


2. Сагателян М.О. Патология околоносовых пазух при муковисцидозе у детей // Автореф. дисс. канд. мед. наук. М., 2002. 29 с.


3. Benammar-Englmaier M, Hallermeier JK, Englmaier B. Alphamimetic effects on nasal mucosa in magnetic resonance tomography. Digitale Bilddiagn 1990;10:46–50.


4. Cimmino M, Tardone M, Cavaliere M, et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg 2005;131:1097–101.


5. Cimmino M, Cavaliere M, Nardone M, et al. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol 2003;28:2:125–32.


6. Cepero R, Smith RJ, Catlin FI, et al. Cystic fibrosis – an otolaryngologic perspective. Otolaryngol Head Neck Surg 1987;97:356–60.


7. Costantini D, Di Cicco M, Giunta A, et al. Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ Carol 1990;36:220–21.


8. Crockett DM, McGill TJ, Healy GB, et al. Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann Otol Rhinol Laryngol 1987;96(4):367–72.


9. Davis PB, Di Sant Agnese PA. Chest Diagnosis and treatment of cystic fibrosis. An update 1995;85:802–09.


10. Davidson TM, Murphy C, Mitchell M, et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995;105:354–58.


11. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001;125:265–69.


12. Davidson TM, Murphy C, Mitchell M, et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995;105:354–58.


13. Eggesbo HB, Dolvik S, Stiris M, et al. Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol 2001;42:2:144–50.


14. Fokkens W, Lund V, Mullol J, et al. EPOS 2007: European position paper on rhinosinusitis and nasal polyps. Rhinology 2007;45:1–139.


15. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331:637–42.


16. Graf PM. Rhinitis medicamentosa. Clin Allergy Immunol 2007;19:295–304.


17. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000;30:481–89.


18. Henriksson G, Westrin KM, Karpati F, et al. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest 2002;121:1:40–7.


19. Harvey R, Hannan SA, Badia L, et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database of Systematic Reviews 2008 Issue 2. Published by John Wiley & Sons, Ltd. DOI: 10.1002/14651858. CD006394.pub2 This version first published online: 18 July 2007 in Issue 3, 2007.


20. Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 2000;38:63–65.


21. Jaffe BF, Strome M, Knaw KT, et al. Nasal polypectomy and sinus surgery for cystic fibrosis – a 10 year review. Otolaryngol Clin North Am 1977;10(1):81–90.


22. Krzeski A, Kapiszewska-Dzedzej D, Gorski NP, et al. Cystic fibrosis in rhinologic practice. Am J Rhinol 2002;16(3):155–60.


23. Kapiszewska-Dzedzej D, Krzeski A, HeldZiolkowska M, et al. Paranasal sinuses CT scans analysis of patients with cystic fibrosis. Otolaryngol Pol 2001;55(4):383–88.


24. Keller M, Schuschnig U, Knoch M, et al. Characterization of nebulized Pulmozyme® administered by the PARI SINUS™ utilizing a human cast model. NACF conference, Denver, Colorado 2006 Nov. 1–4 (poster).


25. Keck T, Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope 2007;117:475–79.


26. Morris PS, Leach AJ. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD001094. Update of: Cochrane Database Syst Rev 2002;(4): CD001094. Antibiotics for persistent nasal discharge (rhinosinusitis) in children.


27. Maniscalco M, Sofia M, Weitzberg E, et al. Sounding airflow enhances aerosol delivery into the paranasal sinuses. Eur J Clin Invest 2006;36(7):509–13.


28. Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am J Med 2004;117(Suppl. 9A):20–5.


29. Mainz J, Koitschev A. Management of chronic rhinosinusitis in CF. J Cystic Fibrosis 2009;8(Suppl. 1):S10–S14.


30. Mainz JG, Mentzel HJ, Schneider G, et al. Sinunasal inhalation of dornase alfa in CF. Results of a double-blind placebo-controlled pilot trial. J Cystic Fibrosis 2008;7:27 (abstract).


31. Nishioka GJ, Barbero GJ, Konig P, et al. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg 1995;113:440–45.


32. Rozsasi A, Keck T. An update on cystic fibrosis for the EN T-specialist. Laryngorhinootologie 2003;82(10):715–25;726–30.


33. Reilly JS, Kenna MA, Stool SE, et al. Nasal surgery in children with cystic fibrosis: complications and risk management. Laryngoscope 1985;95(12):1491–93.


34. Rowe-Jones JM, Mackay IS. Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope 1996;106:1540–54.


35. Sorensen H, Mygind N, Tygstrup I, Winge Flensborg E. Histology of nasal polyps of different etiology. Rhinology 1977; 15(3):121–28.


36. Sobol SE, Christodoulopoulos P, Manoukian JJ, et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis.Arch Otolaryngol Head Neck Surg 2002;128(11):1295–98.


37. Slieker MG, Schilder AG, Uiterwaal CS, et al. Children with cystic fibrosis: who should visit the otorhinolaryngologist? Arch Otolaryngol Head Neck Surg 2002;128(11):1245–48.


38. Stern RC, Boat TF, Wood RE, et al. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982;136(12):1067–70.


39. Shwachman H, Kulczycki LL, Mueller HL, et al. Nasal polyposis in patients with cystic fibrosis. Pediatries 1962;30:389–401.


40. Shah PL, Conway S, Scott SF, et al. A casecontrolled study with dornase alfa to evaluate impact on disease progression over a 4-year period. Respiration 2001;68:160–64.


41. Tos M, Mogensen C, Thomsen J. Nasal polyps in cystic fibrosis. J Laryngol Otol 1977;91(10):827–35.


42. Videler WJ, van Drunen CM, Reitsma JB, et al. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology 2008;46:92–8.


43. Watelet JB, Van Cauwenberge P, Bachert C. Rhinological aspects of cystic fibrosis. Monaldi Arch Chest Dis 2000;55(6):475–77.


Похожие статьи


Бионика Медиа